AI-Powered Imaging Software Aids Coronary Stenting
By HospiMedica International staff writers Posted on 11 May 2021 |
Image: OCT and Ultreon Software image calcium deposits in blood vessels (Photo courtesy of Abbot)
A new imaging platform merges optical coherence tomography (OCT) with artificial intelligence (AI) for enhanced visualization of calcium-based blockages.
The Abbott Laboratories (Abbot Park, IL, USA) OCT technology uses near-infrared (NIR) light and the Dragonfly OpStar imaging catheter to provide high-definition (HD) images from within a blood vessel, improving physicians’ assessment of blockages in those vessels and optimizing decisions related to stent selection, placement, and deployment. The system is powered by Ultreon 1.0 Software to automatically detect degree and thickness of calcification, highlight calcification arc and maximal thickness, display calcification angle and thickness values throughout pullback in real-time, and highlight calcification overlays on the vessel with co-registration views.
In addition, it can automatically detect external elastic lamina (EEL) and lumen to help identify landing zones for accurate stent placement; provide vessel diameter measurements; facilitate measuring of lesion length and identification of optimal user-adjusted stent landing zones; aid stent length selection through co-registration; provide side-by-side viewing of live and co-registered angio to help physicians guide precise stent deployment; and ensure optimal stent expansion and apposition by instantaneous display of expansion and apposition results.
“Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures,” said Nick West, MD, chief medical officer and divisional vice president of global medical affairs at Abbott’s vascular business. “Ultreon Software can potentially improve physician and patient experience by utilizing a systematic process, reducing variability and increasing accuracy of diagnosis and application of therapies.”
“Ultreon’s customizable user interface and AI detection will make decision-making faster and reduce procedural variability, especially for the increasing number of physicians who are learning to utilize OCT imaging over other more traditional imaging technologies,” said Jose Mª de la Torre Hernández, MD, head of interventional cardiology at Hospital Universitario Marques de Valdecilla (Santander, Spain). “The automatic display of details with Ultreon reduces uncertainty during the preparation for stent placement and allows for increased accuracy to help us deliver better care to our patients.”
The Abbott Laboratories (Abbot Park, IL, USA) OCT technology uses near-infrared (NIR) light and the Dragonfly OpStar imaging catheter to provide high-definition (HD) images from within a blood vessel, improving physicians’ assessment of blockages in those vessels and optimizing decisions related to stent selection, placement, and deployment. The system is powered by Ultreon 1.0 Software to automatically detect degree and thickness of calcification, highlight calcification arc and maximal thickness, display calcification angle and thickness values throughout pullback in real-time, and highlight calcification overlays on the vessel with co-registration views.
In addition, it can automatically detect external elastic lamina (EEL) and lumen to help identify landing zones for accurate stent placement; provide vessel diameter measurements; facilitate measuring of lesion length and identification of optimal user-adjusted stent landing zones; aid stent length selection through co-registration; provide side-by-side viewing of live and co-registered angio to help physicians guide precise stent deployment; and ensure optimal stent expansion and apposition by instantaneous display of expansion and apposition results.
“Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures,” said Nick West, MD, chief medical officer and divisional vice president of global medical affairs at Abbott’s vascular business. “Ultreon Software can potentially improve physician and patient experience by utilizing a systematic process, reducing variability and increasing accuracy of diagnosis and application of therapies.”
“Ultreon’s customizable user interface and AI detection will make decision-making faster and reduce procedural variability, especially for the increasing number of physicians who are learning to utilize OCT imaging over other more traditional imaging technologies,” said Jose Mª de la Torre Hernández, MD, head of interventional cardiology at Hospital Universitario Marques de Valdecilla (Santander, Spain). “The automatic display of details with Ultreon reduces uncertainty during the preparation for stent placement and allows for increased accuracy to help us deliver better care to our patients.”
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room